1,097 results on '"Winkler, Jürgen"'
Search Results
2. The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology
3. The comorbidity and co-medication profile of patients with progressive supranuclear palsy
4. Neuroinflammatory disease signatures in SPG11-related hereditary spastic paraplegia patients
5. CSF1R-Mediated Myeloid Cell Depletion Prolongs Lifespan But Aggravates Distinct Motor Symptoms in a Model of Multiple System Atrophy
6. A reversible state of hypometabolism in a human cellular model of sporadic Parkinson’s disease
7. Methods for integrating postural control into biomechanical human simulations: a systematic review
8. The effects of an individualized smartphone-based exercise program on self-defined motor tasks in Parkinson’s disease: a long-term feasibility study
9. Automated assessment of foot elevation in adults with hereditary spastic paraplegia using inertial measurements and machine learning
10. Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances
11. Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study
12. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy
13. Oprema -- The Relay Computer of Carl Zeiss Jena
14. Author Correction: A monocyte gene expression signature in the early clinical course of Parkinsons disease.
15. Author Correction: A monocyte gene expression signature in the early clinical course of Parkinson's disease.
16. The Progressive Supranuclear Palsy Clinical Deficits Scale
17. Cell-Based Therapy and Genome Editing in Parkinson’s Disease: Quo Vadis?
18. Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators
19. Treadmill training and physiotherapy similarly improve dual task gait performance: a randomized-controlled trial in Parkinson’s disease
20. Mobile digital gait analysis captures effects of botulinum toxin in hereditary spastic paraplegia
21. A sensorimotor enhanced neuromusculoskeletal model for simulating postural control of upright standing
22. Transcription factor Olig2 is a major downstream effector of histone demethylase Phf8 during oligodendroglial development
23. Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease
24. Neuropsychology and MRI correlates of neurodegeneration in SPG11 hereditary spastic paraplegia
25. Druggable transcriptomic pathways revealed in Parkinson’s patient-derived midbrain neurons
26. Versicherungsprinzip
27. Familiengerechte Hilfe
28. Haushaltsgemeinschaft
29. Leistungsberechtigte/r
30. Plasma Neurofilaments: Potential Biomarkers of SPG11‐Related Hereditary Spastic Paraplegia
31. Functional gait measures correlate to fear of falling, and quality of life in patients with Hereditary Spastic Paraplegia: A cross-sectional study
32. Brain tissues have single-voxel signatures in multi-spectral MRI
33. Acute exercise following skill practice promotes motor memory consolidation in Parkinson’s disease
34. Polyhydroxyphenylvalerate/polycaprolactone nanofibers improve the life-span and mechanoresponse of human IPSC-derived cortical neuronal cells
35. Novel Homozygous FA2H Variant Causing the Full Spectrum of Fatty Acid Hydroxylase-Associated Neurodegeneration (SPG35)
36. Sobetirome rescues α‐synuclein‐mediated demyelination in an in vitro model of multiple system atrophy
37. The comorbidity and co-medication profile of patients with progressive supranuclear palsy
38. Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis
39. α‐Synuclein Seed Amplification Assays from Blood‐Based Extracellular Vesicles in Parkinson's Disease: An Evaluation of the Evidence.
40. alpha-Synuclein: a Modulator During Inflammatory CNS Demyelination
41. Gait variability as digital biomarker of disease severity in Huntington’s disease
42. Corrigendum to “Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy” Exp Neurol. 2012 April; 234(2): 405–416
43. Layer-specific axonal degeneration of serotonergic fibers in the prefrontal cortex of aged A53T α-synuclein–expressing mice
44. Exploring gait adaptations to perturbed and conventional treadmill training in Parkinson’s disease: Time-course, sustainability, and transfer
45. Sex‐specific pleiotropic changes in emotional behavior and alcohol consumption in human α‐synuclein A53T transgenic mice during early adulthood.
46. Sobetirome rescues α‐synuclein‐mediated demyelination in an in vitro model of multiple system atrophy.
47. Novel Homozygous FA2H Variant Causing the Full Spectrum of Fatty Acid Hydroxylase-Associated Neurodegeneration (SPG35).
48. The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
49. Monitoring medication optimization in patients with Parkinson’s disease
50. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.